The University of Chicago Header Logo

Connection

Walter M. Stadler to Mitotane

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Mitotane.
Walter M. Stadler
Connection Strength
0.121
Mitotane
  1. The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. Horm Cancer. 2014 Aug; 5(4):232-9.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.